Transcranial magnetic stimulation

In September 2024, the Canary Islands Healthcare Evaluation Service (SESCS) is working on several HTAs, including evaluations in neuromodulation, IVD, and some other fields.

On October 5, 2023, the Health Technology Council initiated the evaluation aimed to investigate whether Transcranial Magnetic Stimulation should be used as a treatment option for adult patients with treatment-resistant depression. The expected publication date is not announced yet.

In March 2023, Health Technology Wales published an Evidence Appraisal Report (EAR) and Guidance on photobiomodulation for the prevention and treatment of oral mucositis. Furthermore, seven Medtech-related Topic Exploration Reports (TER) were published, including single-pulse transcranial magnetic stimulation and AI-assisted ultrasound for deep vein thrombosis; however, Health Technology Wales will proceed with a full appraisal on one topic only - digital wound management tools.

In March 2023, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two more projects which received a subsidy under the "Subsidy scheme for promising care" in 2023 for research of focal therapy in intermediate risk prostate cancer and repetitive transcranial magnetic stimulation in paresis due to the cerebral infarction or cerebral hemorrhage.